Literature DB >> 23572150

KCNN4 channels participate in the EMT induced by PRL-3 in colorectal cancer.

Wei Lai1, Lu Liu, Yujie Zeng, Heng Wu, Heyang Xu, Shuang Chen, Zhonghua Chu.   

Abstract

Studies have shown that phosphatase of regenerating liver-3 (PRL-3) promotes the invasion, migration, and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition (EMT). However, the mechanism by which PRL-3 induces tumor cell EMT is unknown. Our previous research revealed that PRL-3 promotes LoVo cell proliferation by up-regulating KCNN4 channels. In the current study, we explored the mechanism by which PRL-3 mediates EMT. We demonstrated that PRL-3 induced the expression of KCNN4 channels, leading to EMT and the down-regulation of E-cadherin. Further studies revealed that KCNN4 channels increased intracellular calcium levels and activated components of cell signaling downstream of calcium, including CaM-kinase II and glycogen synthase kinase-3 beta (GSK-3 beta), which increased Snail expression. Inhibiting KCNN4 with siRNA and TRAM-34, a specific inhibitor, restored E-cadherin expression and inhibited Snail expression. These results implicated the up-regulation of KCNN4 channels in the PRL-3-mediated induction of EMT and promotion of cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23572150     DOI: 10.1007/s12032-013-0566-z

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  26 in total

1.  Calcium-activated potassium channels sustain calcium signaling in T lymphocytes. Selective blockers and manipulated channel expression levels.

Authors:  C M Fanger; H Rauer; A L Neben; M J Miller; H Rauer; H Wulff; J C Rosa; C R Ganellin; K G Chandy; M D Cahalan
Journal:  J Biol Chem       Date:  2001-01-22       Impact factor: 5.157

Review 2.  Cellular signaling through multifunctional Ca2+/calmodulin-dependent protein kinase II.

Authors:  T R Soderling; B Chang; D Brickey
Journal:  J Biol Chem       Date:  2000-11-28       Impact factor: 5.157

3.  Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling.

Authors:  W F Matter; T Estridge; C Zhang; R Belagaje; L Stancato; J Dixon; B Johnson; L Bloem; T Pickard; M Donaghue; S Acton; R Jeyaseelan; V Kadambi; C J Vlahos
Journal:  Biochem Biophys Res Commun       Date:  2001-05-25       Impact factor: 3.575

4.  PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition.

Authors:  Haihe Wang; Samantha Yiling Quah; Jing Ming Dong; Edward Manser; Jing Ping Tang; Qi Zeng
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

5.  Blockage of intermediate-conductance-Ca(2+) -activated K(+) channels inhibits progression of human endometrial cancer.

Authors:  Z H Wang; B Shen; H L Yao; Y C Jia; J Ren; Y J Feng; Y Z Wang
Journal:  Oncogene       Date:  2007-02-19       Impact factor: 9.867

6.  PRL-3 promotes the proliferation of LoVo cells via the upregulation of KCNN4 channels.

Authors:  Wei Lai; Shuang Chen; Heng Wu; Yufeng Guan; Lu Liu; Yujie Zeng; Haiyan Zhao; Jianmin Jiang; Zhonghua Chu
Journal:  Oncol Rep       Date:  2011-06-28       Impact factor: 3.906

7.  Role of cholinergic-activated KCa1.1 (BK), KCa3.1 (SK4) and KV7.1 (KCNQ1) channels in mouse colonic Cl- secretion.

Authors:  J E Matos; M Sausbier; G Beranek; U Sausbier; P Ruth; J Leipziger
Journal:  Acta Physiol (Oxf)       Date:  2007-03       Impact factor: 6.311

8.  High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study.

Authors:  U A Miskad; S Semba; H Kato; Y Matsukawa; Y Kodama; E Mizuuchi; N Maeda; K Yanagihara; H Yokozaki
Journal:  Virchows Arch       Date:  2007-01-18       Impact factor: 4.064

9.  Intermediate-conductance Ca2+-activated K+ channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry.

Authors:  H Lallet-Daher; M Roudbaraki; A Bavencoffe; P Mariot; F Gackière; G Bidaux; R Urbain; P Gosset; P Delcourt; L Fleurisse; C Slomianny; E Dewailly; B Mauroy; J L Bonnal; R Skryma; N Prevarskaya
Journal:  Oncogene       Date:  2009-03-09       Impact factor: 9.867

10.  Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells.

Authors:  Unn-Merete Fagerli; Randi U Holt; Toril Holien; Thea K Vaatsveen; Fenghuang Zhan; Kjartan W Egeberg; Bart Barlogie; Anders Waage; Harald Aarset; Hong Yan Dai; John D Shaughnessy; Anders Sundan; Magne Børset
Journal:  Blood       Date:  2007-10-12       Impact factor: 22.113

View more
  23 in total

1.  Glucose-regulated protein 78 (GRP78) regulates colon cancer metastasis through EMT biomarkers and the NRF-2/HO-1 pathway.

Authors:  Yu-Jia Chang; Wei-Yu Chen; Chien-Yu Huang; Hui-Hsiung Liu; Po-Li Wei
Journal:  Tumour Biol       Date:  2014-11-28

Review 2.  Molecular mechanisms of tumour invasion: regulation by calcium signals.

Authors:  Oksana Iamshanova; Alessandra Fiorio Pla; Natalia Prevarskaya
Journal:  J Physiol       Date:  2017-04-21       Impact factor: 5.182

3.  Potassium and Calcium Channel Complexes as Novel Targets for Cancer Research.

Authors:  Marie Potier-Cartereau; William Raoul; Gunther Weber; Karine Mahéo; Raphael Rapetti-Mauss; Maxime Gueguinou; Paul Buscaglia; Caroline Goupille; Nelig Le Goux; Souleymane Abdoul-Azize; Thierry Lecomte; Gaëlle Fromont; Aurélie Chantome; Olivier Mignen; Olivier Soriani; Christophe Vandier
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

Review 4.  Epithelial-mesenchymal transition process during embryo implantation.

Authors:  Farnaz Oghbaei; Reza Zarezadeh; Davoud Jafari-Gharabaghlou; Minoo Ranjbar; Mohammad Nouri; Amir Fattahi; Kazuhiko Imakawa
Journal:  Cell Tissue Res       Date:  2022-01-13       Impact factor: 5.249

Review 5.  Phosphatase of regenerating liver: a novel target for cancer therapy.

Authors:  Amanda M Campbell; Zhong-Yin Zhang
Journal:  Expert Opin Ther Targets       Date:  2014-03-01       Impact factor: 6.902

6.  HOXB9 promotes epithelial-to-mesenchymal transition via transforming growth factor-β1 pathway in hepatocellular carcinoma cells.

Authors:  Lin Sha; Lei Dong; Li Lv; Lizhi Bai; Xuening Ji
Journal:  Clin Exp Med       Date:  2014-08-01       Impact factor: 3.984

7.  A chemical genetics approach identifies PTP4A3 as a regulator of colon cancer cell adhesion.

Authors:  Kelley E McQueeney; Joseph M Salamoun; Jennifer G Ahn; Paula Pekic; Isabella K Blanco; Heather L Struckman; Elizabeth R Sharlow; Peter Wipf; John S Lazo
Journal:  FASEB J       Date:  2018-05-10       Impact factor: 5.191

8.  The TRPV4-TAZ mechanotransduction signaling axis in matrix stiffness- and TGFβ1-induced epithelial-mesenchymal transition.

Authors:  Shweta Sharma; Rishov Goswami; Shaik O Rahaman
Journal:  Cell Mol Bioeng       Date:  2018-12-04       Impact factor: 2.321

9.  Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis.

Authors:  Bo Chen; Donghong Sun; Xiuni Qin; Xing-Hua Gao
Journal:  Invest New Drugs       Date:  2021-01-26       Impact factor: 3.850

10.  KCNN4-mediated Ca2+/MET/AKT axis is promising for targeted therapy of pancreatic ductal adenocarcinoma.

Authors:  Xiao Mo; Cheng-Fei Zhang; Ping Xu; Min Ding; Zhi-Jie Ma; Qi Sun; Yu Liu; Hong-Kai Bi; Xin Guo; Alaa Abdelatty; Chao Hu; Hao-Jun Xu; Guo-Ren Zhou; Yu-Liang Jia; Hong-Ping Xia
Journal:  Acta Pharmacol Sin       Date:  2021-06-28       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.